IMPACT

Genome Atlantic has consistently strived to drive meaningful impact through all our activities. Realizing the importance of quantifying this impact, we recently enlisted The Evidence Network to conduct a comprehensive Impact Assessment spanning the five-year period from 2018 to 2023. Their findings pointed to a remarkable return on investment and tangible outcomes:

• Every public sector dollar invested in Genome Atlantic yielded $23 in applied R&D investment and $59 to GDP.
• Genome Atlantic’s efforts enabled $60 million in new impact-driven genomics R&D – of which $21 million or roughly 30%, was private sector investment.
• Total funds attracted by and invested in Genome Atlantic during the last five years resulted in an estimated $178.7 million of output, $122.2 million contributions to GDP, $8.9 million in provincial and federal tax revenues, and 927 jobs.
• The Impact Assessment also included several compelling case studies from many different sectors, showcasing the power of genomics to boost production, increase sustainability and improve health and well-being.

The Impact Assessment also included several compelling case studies from many different sectors, showcasing the power of genomics to boost production, increase sustainability and improve health and well-being.